The need for reliable temperature control for advanced drug products
How to ensure safety and sustainability in the global market for advanced therapies
Add bookmark
We respect your privacy, by clicking "Download Your Copy" you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
Demand is rising for cold chain solutions, from freezers inside labs and production units to the single-dose packages delivered to patients’ homes or hospital infusion centers.
Additionally, there is a race to keep up with advances in science, such as developments in CAR-T and CRISPR technologies that have opened up new avenues for how to identify, modify and apply therapies.
Key to all of this is how these new therapies will reach patients, requiring precise temperature control, often in cryogenic ranges, to remain viable and potent.
Read this article by Nick Basta, founder and former editor-in-chief of Pharmaceutical Commerce, to find out:
- What advanced therapy medical products (ATMPs) are, and what challenges they present to the pharma and healthcare sectors
- The new regulatory requirements to ensure the efficacy of ATMPs
- Why reliable temperature control for ATMPs is vital for the growth of the industry
For the full version of this report visit Safety and Sustainability in the Global ATMP Market (2022)
